Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

November 01, 2018; Volume 94,Issue 5

Articles

  • Chemoproteomic Discovery of a Ritanserin-Targeted Kinase Network Mediating Apoptotic Cell Death of Lung Tumor Cells
    You have access
    Chemoproteomic Discovery of a Ritanserin-Targeted Kinase Network Mediating Apoptotic Cell Death of Lung Tumor Cells
    Sean T. Campbell, Caroline E. Franks, Adam L. Borne, Myungsun Shin, Liuzhi Zhang and Ku-Lung Hsu
    Molecular Pharmacology November 2018, 94 (5) 1246-1255; DOI: https://doi.org/10.1124/mol.118.113001
  • You have access
    The Novel Activity of Carbamazepine as an Activation Modulator Extends from NaV1.7 Mutations to the NaV1.8-S242T Mutant Channel from a Patient with Painful Diabetic Neuropathy
    Chongyang Han, Andreas C. Themistocleous, Mark Estacion, Fadia B. Dib-Hajj, Iulia Blesneac, Lawrence Macala, Carl Fratter, David L. Bennett, Stephen G. Waxman and Sulayman D. Dib-Hajj
    Molecular Pharmacology November 2018, 94 (5) 1256-1269; DOI: https://doi.org/10.1124/mol.118.113076
  • Activation of <em>Caenorhabditis elegans</em> Levamisole-Sensitive and Mammalian Nicotinic Receptors by the Antiparasitic Bephenium
    You have access
    Activation of Caenorhabditis elegans Levamisole-Sensitive and Mammalian Nicotinic Receptors by the Antiparasitic Bephenium
    Ornella Turani, Guillermina Hernando, Jeremías Corradi and Cecilia Bouzat
    Molecular Pharmacology November 2018, 94 (5) 1270-1279; DOI: https://doi.org/10.1124/mol.118.113357
  • You have access
    Effects of HCN Channels in the Rostral Ventrolateral Medulla Contribute to the Cardiovascular Effects of Propofol
    Zhiqiang Hu, Zhilin Wu, Jie Gao, Qi Jia, Na Li, Yeling Ouyang, Shanglong Yao and Xiangdong Chen
    Molecular Pharmacology November 2018, 94 (5) 1280-1288; DOI: https://doi.org/10.1124/mol.118.111898
  • You have access
    Molecular Characterization of Binding Loop E in the Nematode Cys-Loop GABA Receptor
    Ariel Kwaka, Mohammad Hassan Khatami, Joshua Foster, Everett Cochrane, Sarah A. Habibi, Hendrick W. de Haan and Sean G. Forrester
    Molecular Pharmacology November 2018, 94 (5) 1289-1297; DOI: https://doi.org/10.1124/mol.118.112821
  • You have access
    Utility of an “Allosteric Site-Impaired” M2 Muscarinic Acetylcholine Receptor as a Novel Construct for Validating Mechanisms of Action of Synthetic and Putative Endogenous Allosteric Modulators
    Ee Von Moo, Patrick M. Sexton, Arthur Christopoulos and Celine Valant
    Molecular Pharmacology November 2018, 94 (5) 1298-1309; DOI: https://doi.org/10.1124/mol.118.112490

Errata

  • You have access
    Correction to “Loss of Cyclosporin and Azidopine Binding Are Associated with Altered ATPase Activity by a Mutant P-glycoprotein with Deleted Phe335”
    Molecular Pharmacology November 2018, 94 (5) 1310; DOI: https://doi.org/10.1124/mol.117.769err
  • You have access
    Correction to “CCAAT/Enhancer-Binding Protein β (Nuclear Factor for Interleukin 6) Transactivates the Human MDR1 Gene by Interaction with an Inverted CCAAT Box in Human Cancer Cells”
    Molecular Pharmacology November 2018, 94 (5) 1311; DOI: https://doi.org/10.1124/mol.117.906err
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 94 (5)
Molecular Pharmacology
Vol. 94, Issue 5
1 Nov 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Articles
  • Errata
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics